2003
DOI: 10.2190/u99g-xdml-0grg-bye0
|View full text |Cite
|
Sign up to set email alerts
|

Severe Cardiovascular Side Effects of Olanzapine in an Elderly Patient: Case Report

Abstract: Olanzapine, an atypical antipsychotic, is often regarded as a safe choice for psychosis management. We hereby report an aged case that presented with conscious depression, bradycardia, hypotension, miosis and hypothermia. Olanzapine was thought to be the offending agent. His condition improved with supportive therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
16
0
1

Year Published

2004
2004
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(18 citation statements)
references
References 8 publications
1
16
0
1
Order By: Relevance
“…There was no recurrence on administration of aripiprazole. There are few reports of hypotension associated with olanzapine, 4 , 5 ) one in an elderly individual, and the other with intramuscular administration. The summary of product characteristics for olanzapine reports 5% subjects develop orthostatic hypotension as compared to 2% in placebo, 6 ) which is much less as compared to the rates observed with first generation antipsychotics.…”
Section: Discussionmentioning
confidence: 99%
“…There was no recurrence on administration of aripiprazole. There are few reports of hypotension associated with olanzapine, 4 , 5 ) one in an elderly individual, and the other with intramuscular administration. The summary of product characteristics for olanzapine reports 5% subjects develop orthostatic hypotension as compared to 2% in placebo, 6 ) which is much less as compared to the rates observed with first generation antipsychotics.…”
Section: Discussionmentioning
confidence: 99%
“…We suspect that hypotension and bradycardia in our patient were provoked by olanzapine use, namely by blockage of the α 2 -adrenergic receptors [15]. The latter might also increase the hypothermic effect by inhibiting peripheral responses to cooling of the body [9].…”
Section: Discussionmentioning
confidence: 77%
“…This is the twelfth reported patient with olanzapine-induced hypothermia and the youngest pediatric patient with olanzapine-induced hypothermia described in the literature (PubMed Search for olanzapine and hypothermia 13.09.2011) (see Table 1) [5][6][7][8][9][12][13][14][15][16]. According to the literature, the risk of hypothermia is highest following initiation of the drug or after an increase in dosage.…”
Section: Literature Reviewmentioning
confidence: 86%
“…Since olanzapine exerts also influences on cholinergic, adrenergic and histaminergic pathways, an involvement of these pathways cannot be excluded [36]. The therapy of the rare but dangerous hypothermia caused by olanzapine [37] cannot comprehend substances affecting the orexinergic system to elevate body temperature: this system is blocked by olanzapine. We can suppose that the body weight gain could be caused, at least in part, by a decrease in the thermogenic changes due to orexin A.…”
Section: Discussionmentioning
confidence: 99%